Paper
0
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
Authors
Adam Cohen,Alfred Garfall
Edward Stadtmauer,J. Melenhorst,Simon Lacey,Eric Lancaster,Dan Vogl,Brendan Weiss,Karen Dengel,Annemarie Nelson,Gabriela Plesa,Fang Chen,Megan Davis,Wei‐Ting Hwang,Regina Young,Jennifer Brogdon,Randi Isaacs,Iulian Pruteanu-Malinici,Don Siegel,Bruce Levine,Carl June
+19 authors
,Michael MilonePublished
Mar 21, 2019
Show more
Save
Tip0
TipSave
Abstract
BACKGROUND. CAR T cells are a promising therapy for hematologic malignancies. B cell maturation antigen (BCMA) is a rational target in multiple myeloma (MM).
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.